SUMMAR Y Many sleep centres employ a preliminary screening test in order to reduce the number of polysomnographies required in the routine diagnosis of the sleep apnoea ⁄ hypopnoea syndrome (SAHS). We investigated the combination of heart rate and oximetry information as a means of performing this test. A retrospective study of 100 patients with suspected SAHS was made. All patients had in-hospital polysomnography on one night. We estimated the number of respiratory event-related arousals by counting the number of autonomic arousals (assessed on the basis of changes in the heart interbeat interval) that were coincident with a rise in oximetry. The hourly index of such events was denoted the Ôcardiac-oximetry disturbance indexÕ (CODI). The median apnoea ⁄ hypopnoea index (AHI) was 16.5 (range 1.0-93.6) h )1 . The CODI correlated significantly with the AHI (Spearman correlation coefficient r s ¼ 0.88, P < 0.01), and the area (± standard error) under the receiver operating characteristic (ROC) was 0.94 ± 0.05. Oximetry alone (based on 4% dips) was a less effective screening test (r s ¼ 0.80, P < 0.01; area under ROC 0.83 ± 0.06). Using 2% dips in oximetry offered comparable performance with the CODI (r s ¼ 0.91, P < 0.01; area under ROC 0.93 ± 0.04). The CODI was better correlated with the electroencephalograph arousal index (r s ¼ 0.84, P < 0.01) than was oximetry (2% dips, r s ¼ 0.57, P < 0.01). The CODI algorithm also offers an informal measure of self-validation: a large discrepancy between the number of autonomic arousals and the number of rises in oximetry indicates the presence of autonomic arousals without changes in oximetry (or vice versa). This self-validation mechanism identified several patients in this study, and may be useful in identifying sleep disruption due to chronic pain or other causes.
INTRODUCTION
The most widely accepted diagnostic test for the sleep apnoea ⁄ hypopnoea syndrome (SAHS) is overnight polysomnography (PSG). The expensive and time-consuming nature of PSG prompts many sleep centres to perform an initial screening test in order to reduce the number of PSGs needed. It is desirable that this test has high specificity to the SAHS because a positive result coupled with an appropriate history allows a patient to proceed directly to treatment without the need for PSG (Bennett & Kinnear 1999) . Overnight oximetry is commonly used to perform this test because, if one looks for repetitive, profound desaturations, it is indeed highly specific to the SAHS (Douglas et al. 1992; Golpe et al. 1999; Ryan et al. 1995) . However, the sensitivity of oximetry with such criteria is generally poor -as low as 30% (Golpe et al. 1999) . Thus, many patients with the SAHS display normal oximetry and must proceed to PSG before a confident diagnosis can be made.
The poor sensitivity of oximetry has prompted the development of other screening tests, many of which are based on markers of autonomic arousal, such as variations in heart rate (Guilleminault et al. 1984; Pitson et al. 1994) , peripheral vasoconstriction (Schnall et al. 1999) , and pulse transit time (Pitson & Stradling 1998) . Such markers are, at least in part, manifestations of the orienting reflex response to alerting stimuli during sleep. This reflex does not habituate to recurrent arousing stimuli (Johnson & Lubin 1967) and so is thought to be a sensitive marker of transient arousal stimuli (Davies et al. 1993) . However, autonomic arousals such as these are not specific to the SAHS; similar autonomic changes are seen in response to spontaneous arousals (Bonnet & Arand 1997) as well as in other sleep disorders such as the periodic limb movement syndrome (PLMS) (Winkelman 1999) and bruxism (Bader et al. 1997) .
In this study, we have combined two independent markers of arousal. Information regarding the termination of respiratory events was sought in both the oximetry and RR (heart interbeat) interval signals, and the information combined to form an hourly estimate of the number of arousals from sleep caused by respiratory events.
METHODS
The study was approved by the local research and ethics committee. A retrospective study of patients who underwent PSG for suspected SAHS between June 1996 and May 2001 at the Birmingham Heartlands Hospital Sleep Disorders Unit was made. One hundred and twenty PSG studies were selected at random from a total of 1051 recorded during this period.
The inclusion criterion was a referral for suspected SAHS. A small number (10 patients) were referred by ENT specialists with a history of snoring without excessive daytime somnolence or witnessed apnoea. All other patients had a history of snoring, witnessed apnoea, or excessive daytime somnolence not better explained by other causes. The exclusion criteria were kept to a minimum so that the study population would represent a typical cross-section of patients referred for suspected SAHS. Patients with hypoxic lung disease (awake oxygen saturation below 90%) were excluded (n ¼ 1), as were poor quality recordings (sufficient to cause difficulty either in staging sleep or scoring respiratory disturbances, n ¼ 7, or those with a high level of artefact (more than an average of 5 min h )1 ) in either the saturation record or electrocardiogram, n ¼ 11). One recording was also excluded as the patient's hospital notes had been lost. Thus of the 120 recordings selected, a total of 20 were excluded. The 100 remaining recordings were divided into a development set and a validation set. Recordings were added to the development set until the algorithm was judged to be sufficiently refined. The remaining recordings were then used for validation purposes. The development set was used to develop the algorithm and to refine the parameter values (e.g. choice of resaturation criterion; see below) without any referral to the validation data. The final algorithm was then applied without further alteration to the data from the validation set. Due to an oversight in the analytical protocol, recordings were added to the development set in chronological order (according to study date) rather than randomly from the 100 available. The development set consisted of recordings made between June 1996 and August 2000, whereas the validation set used recordings made between March 2000 and May 2001 (the overlap of the two date ranges was due to additional recordings being added after some exclusions).
Patients were studied in hospital on one occasion with overnight PSG (Compumedics S-series ⁄ W-series, Abbotsford, Australia). The PSG montage comprised two central electroencephalograph (EEG) channels (C4-A1 and C3-A2), left and right electrooculograph, submental electromyograph, left and right piezoelectric anterior tibial sensors, oro-nasal airflow thermistor, snore microphone, thoracic and abdominal movement by inductive plethysmography, arterial oxyhaemoglobin saturation by finger pulse oximetry (Pulsox-7, Minolta Co., Osaka, Japan), and ECG modified lead II). The ECG was sampled at 250 Hz, 16 bit resolution, and oximetry was sampled at 1 Hz, 16 bit resolution. All analyses were performed manually by the same technician. Standard criteria were used for scoring sleep stage (Rechtschaffen & Kales 1968) , respiratory events (American Academy of Sleep Medicine Task Force 1999), periodic limb movements (Coleman 1982) and cortical arousals (Sleep Disorders Atlas Task Force 1992). The oximetry and ECG signals (from the onset of sleep, defined as the first occurrence of at least three consecutive epochs of sleep, until the final awakening of the night) were saved from the PSG system to separate files and processed off-line by a computerized algorithm. This algorithm was based on two separate markers of arousal: resaturations (rises) in oximetry, and autonomic arousals, assessed on the basis of changes in the RR interval signal. The algorithm parameters were chosen so that the resaturation index and the autonomic arousal index were both highly sensitive to the SAHS. It was expected that such choices would necessarily yield low specificity for each of these two markers, but we speculated that the combination of the two, wherein only resaturations that were temporally coincident with an autonomic arousal were retained, would be highly specific to the SAHS, while offering better sensitivity than oximetry alone.
Resaturations were evaluated on the basis of the slope of the oximetry signal: any rise of 1.5% over a 10-s window was marked as a resaturation event. A change of 1.5% is small compared with the 4% changes in oximetry that are typically used when screening for the SAHS (Bennett & Kinnear 1999) ; this value was selected to ensure high sensitivity of the resaturation index to the SAHS. The absolute error of the oximeter used in this study is typically ±2%, and so the use of a 1.5% rise may appear to be ill-advised. However, it should be noted that the absolute error is the difference between a given oximeter value and the true arterial oxygen saturation, and that this error is not important in the context of this algorithm. The relative error (that is, the difference in absolute error from one sample to the next) will dominate the algorithm error, and this is much less than the absolute error (Minolta corporation, personal communication).
Autonomic arousals were identified on the basis of changes in the RR interval tachogram. The RR interval tachogram was derived from the ECG and all RR intervals resulting from ectopic beats were deleted (intervals lying outside of 3 SD from the mean were removed, followed by visual inspection of the tachogram and manual removal of remaining ectopic beats). However, we note that the algorithm outlined below is unlikely to be adversely affected by occasional ectopic beats in an otherwise normal ECG. While there is some risk that these may be mistaken by the algorithm as autonomic arousal, they will not be matched by an oximetry resaturation and so will not affect the final algorithm output. In order to obtain evenly sampled interbeat interval data, the RR interval tachogram was interpolated using a cubic spline and resampled at a 1-Hz rate (Task Force 1996) . The resampled signal was low-pass filtered to remove respiratory sinus dysrhythmia. This filtering was implemented by constructing a three-scale approximation to the resampled RR interval signal, using Daubechies' four-coefficient orthonormal wavelet (Wiklund et al. 1997) . Arousal from sleep has been found to cause a characteristic pattern of rise and fall in heart rate (Pitson et al. 1994; Winkelman 1999) . In this study, autonomic arousals were identified according to the following template: a decrease of at least 60 ms over a 10-s window in the filtered RR interval signal, followed within 20 s by a rise of at least 85 ms over a 10-s window. In order to avoid multiple detections from a single arousal, autonomic arousals detected within 10 s of a previous autonomic arousal were disregarded. This template employed relatively small changes in the RR interval signal in order to ensure high sensitivity of the autonomic arousal index to the SAHS. Assuming an average mean heart rate of 65 bpm, a decrease of 60 ms in RR interval is equivalent to a rise in heart rate of about 5 bpm, a value that is less than published results. Garpestad et al. (1992) found an average tachycardia of 11 ± 4 bpm on arousal from obstructive apnoea.
The resaturation and heart rate criteria were deliberately chosen so that the two indices would each be highly sensitive to the SAHS; as explained above, we speculated that the combination of these two sensitive markers would yield a single index that was both specific and sensitive to the SAHS. The information regarding resaturation and autonomic arousal was combined to form an estimate of the hourly number of respiratory event-related arousals. This estimate, denoted the Ôcardiac-oximetry disturbance indexÕ (CODI), was computed by counting the number of autonomic arousals that were followed within 40 s by resaturation. The CODI was compared with PSG-derived indices and the Epworth sleepiness score (Johns 1991) . The performance of the CODI for screening purposes was also compared with that of oximetry alone, using the algorithm published by George et al. (1988) . This algorithm used a 12-s sample period, recording the minimum oximetry value in each of the sample periods. Dips of 4% or more from a continuously updated maximum value were considered significant, and an individual dip extended from the time of the dip until a rise of 3% or more was seen. The hourly index of such dips is denoted here by ODI-4. It has been shown that long averaging times can lead to underestimation of transient changes in oximetry (Farre´et al. 1998) . Consequently, we also examined the performance of 3% dips in oximetry (using a 2% rise as the terminus of each event) and 2% dips (using a 1% rise). These are denoted ODI-3 and ODI-2.
For the purpose of analysis, the SAHS was defined on the basis of an apnoea ⁄ hypopnoea index (AHI) of 15 h )1 or more. This is considered by the American Academy of Sleep Medicine to be the upper limit of mild SAHS (American Academy of Sleep Medicine Task Force 1999). Minimal adverse health effects begin to appear at an AHI of 5 h
; the increased risk of developing hypertension becomes substantial at an AHI of 30 h )1 (Young et al. 1997) . The use of PSG as a gold standard for the diagnosis of the SAHS is a commonly adopted position, but with several limitations. The AHI is dependent on the polysomnographic sensors and the diagnostic definitions used, and can vary widely from clinic to clinic (Moser et al. 1994; Redline et al. 2000) . The AHI is also not necessarily a good predictor of daytime sleepiness (Dealberto et al. 1994) nor of response to treatment with nasal continuous positive airway pressure (CPAP) (McNicholas 2000) . Our decision to adopt PSG as a gold standard was prompted by convention, as there is not yet a widely accepted alternative. However, in our discussion we have included information regarding cases who improved on CPAP in spite of a negative PSG test. A trial of CPAP treatment was offered to all patients for whom obstructive SAHS was confirmed by PSG with an AHI of 15 h )1 or greater, and for whom CPAP treatment was not contraindicated. Some patients with obstructive SAHS but an AHI of less than 15 h )1 were also offered a trial of CPAP at the discretion of the clinician. Trials of CPAP treatment lasted 1 month each. The patient response to CPAP was deemed to be positive if there was both symptomatic improvement (assessed by Epworth sleepiness score and clinical interview) and adequate compliance throughout the trial (assessed by the clinician, with reference to the machine's internal compliance meter where possible). We acknowledge that these assessment criteria are not strong; however, the local clinical protocol used to assess response to CPAP varied across the duration of the study. These criteria were the most stringent which could consistently be applied to all trials. We present the CPAP response data for interest but would recommend further investigation in this regard.
RESULTS
Fifty-five patients (11 females) were included in the development set and 45 (10 females) in the validation set. The patient characteristics are summarized in Table 1 . None of the age, body mass index, AHI, EEG arousal index, or Epworth sleepiness score variables differed significantly between the development and validation sets (Mann-Whitney test at P ¼ 0.05). Thirty patients in the development set and 27 in the validation set showed an AHI in excess of 15 h )1 and were deemed to be suffering from the SAHS. The study population included a number of patients with comorbidities: asthma (n ¼ 7 in the development set and n ¼ 3 in the validation set), non-insulin-dependent diabetes (n ¼ 3 and 1), hypertension (n ¼ 7 and 6), epilepsy (n ¼ 2 and 0), PLMS (n ¼ 2 and 3) and conditions causing nocturnal pain, such as fibromyalgia (n ¼ 5 and 8). Many patients were also taking drugs known to affect either sleep patterns or the autonomic control of the heart: salbutamol (n ¼ 7 and 3), selective serotonin re-uptake inhibitors (SSRIs) (n ¼ 2 and 4), beta-adrenoceptor blockers (n ¼ 2 and 5), and non-steroidal anti-inflammatory analgesics (NSAID) (n ¼ 3 and 5).
We first present summary results of the algorithm on the development data and then give more detailed results of the validation set and in various patient subgroups.
Results on development data
The resaturation and autonomic arousal indices both overestimated the AHI, as expected (Wilcoxon paired sample test, P < 0.001). Only three patients showed an autonomic arousal index that was less than the AHI; similarly, three resaturation indices were less than the AHI (one patient was lower in both respects). Combining the resaturation and autonomic arousal indices to form the CODI yielded a sensitivity of 70% at a specificity of 96%, using a CODI cut-off score of 28.2 h )1 (the cut-off was chosen to give a specificity of at least 95%). The area (±SE) under the receiver operating characteristic (ROC) was 0.94 ± 0.03. The scatter plot of the CODI against the AHI is shown in Fig. 1 . The CODI was also a fair predictor of the EEG arousal index, with an area under the ROC of 0.79 ± 0.07. The difference between the autonomic arousal index and the resaturation index is shown in Fig. 2 . The majority of the points lie between )20 h )1 and 40 h )1
, but there are two outlying groups of points: three patients showed a difference of over 45 h )1 (these patients will be referred to as group A), and four patients showed a difference of less than )25 h )1 (group B). A large discrepancy between these two indices indicates resaturation without autonomic arousal (or vice versa). We speculated during the development of the algorithm that a large difference between these two indices may cast doubt on the validity of the associated CODI score and that this may be used as a Ôself-checkÕ of the CODI algorithm. Excluding these seven results improved the sensitivity of the CODI to 85% at a specificity of 95%, using a cut-off score for the CODI of 24 h )1
. The area under the ROC (with respect to the AHI) rose to 0.96 ± 0.03 and the area under the ROC (with respect to the EEG arousal index) to 0.82 ± 0.07.
The index of 4% dips in oximetry yielded poor sensitivity to the SAHS, as expected (53% sensitivity at 96% specificity). Of the indices derived from oximetry alone, the index of 2% dips (ODI-2) was the best predictor of the AHI, with a sensitivity and specificity of 73 and 96%, respectively, and an area under the ROC of 0.86 ± 0.05. The ODI-2 index performed similarly to the CODI when predicting EEG arousal index, with an area under the ROC of 0.77 ± 0.08. Interestingly, excluding groups A and B (see above) also improved the performance of the oximetry indices: for example, the sensitivity of the ODI-2 increased to 81%, the area under the ROC (with respect to the AHI) to 0.94 ± 0.03 and the area under the ROC (with respect to the EEG arousal index) to 0.86 ± 0.06.
Results on validation data
The resaturation and autonomic arousal indices were again overestimates of the AHI (P < 0.001), although nine patients (out of 45) showed an autonomic arousal index that was lower than their AHI. Only one patient in the validation set showed a resaturation index lower than the AHI.
The scatter plot of the CODI against the AHI is shown in Fig. 3 ; the difference between the autonomic arousal index and the resaturation index is shown in Fig. 4 . The performance of the CODI and oximetry indices for diagnosing the SAHS is summarized by the ROC plots in Fig. 5 . Using the same threshold used on the development set (28.2 h )1
) the CODI yielded a sensitivity of 52% at a specificity of 89%, considerably worse than that obtained on the development set. The area under the ROC (with respect to the AHI) was 0.75 ± 0.07; with respect to the EEG arousal index 0.77 ± 0.07. Assessing the differences between the autonomic arousal and resaturation indices identified four patients with a difference greater than 45 h )1 (hereon referred to as group Av) and 14 patients with a difference less than )25 h )1 (group Bv).
Excluding groups Av and Bv improved the performance of the CODI: sensitivity rose to 87% (two false negative results), specificity to 83% (two false positive results), the area under the ROC (with respect to the AHI) rose to 0.94 ± 0.05 and the area under the ROC (with respect to the EEG arousal index) to 0.93 ± 0.05. The ODI-4 again offered poor sensitivity (59%). The performance of the ODI-2 on the validation data was slightly better than on the development data, with a sensitivity of 78% and specificity of 100%. The area under the ROC (with respect to the AHI) was 0.93 ± 0.04, and with respect to the EEG arousal index was 0.75 ± 0.07. Excluding groups Av and Bv in this instance decreased performance: sensitivity dropped to 67%, specificity to 92%, and the area under the ROC (with respect to the AHI) to 0.89 ± 0.06. The area under the ROC (with respect to the EEG arousal index), however, increased to 0.82 ± 0.08.
The Spearman correlations between various markers of sleep fragmentation are shown in Table 2 . Without excluding those results that failed their CODI self-check, the CODI was less strongly correlated with the AHI and the Epworth sleepiness score than were any of the oximetry indices. The correlation with the EEG arousal index was approximately the same for the CODI (r s ¼ 0.59) and the ODI-2 (r s ¼ 0.57). Excluding groups Av and Bv improved the correlation of the CODI with the other markers of sleep fragmentation (r s ¼ 0.88 with AHI, r s ¼ 0.47 with Epworth, r s ¼ 0.84 with EEG, Table 2 ). Excluding groups Av and Bv improved the correlation of the oximetry-derived indices with the ESS and EEG arousal index, but decreased the correlation of the oximetry-derived indices with the AHI.
Twenty-seven of the 45 patients in the validation set undertook a therapeutic trial of CPAP with 20 positive respondents. The ability of the CODI algorithm to predict a successful response to CPAP was better than that of the ODI-2 index: the respective areas under the ROC were 0.64 ± 0.12 and 0.56 ± 0.13. Interestingly, the predictive power of the CODI in this respect was marginally better than that of the Table 3 shows the classification accuracy of the CODI algorithm on various subgroups of patients, on both the development and validation data. Of those patients who passed the CODI algorithm self-check, there were only three misclassifications (two asthmatic patients and one hypertensive). The numbers of each group that failed this self-check are also given: for example, five of the six patients in the study taking SSRIs failed the self-check, as did seven of the 13 patients complaining of nocturnal pain.
Results with comorbidities and pharmacological agents

DISCUSSION
The performance of the CODI algorithm in predicting the presence of the SAHS was better than that obtained by counting 4% dips in oximetry. The index of 2% dips, however, offered similar performance to the CODI. The areas under the AHI, apnoea ⁄ hypopnoea index; ESS, Epworth Sleepiness Scale; EEG, electroencephalographic arousal index; CODI, cardiac-oximetry disturbance index; ODI-x, oximetry disturbance index (using x% dips). *P < 0.05; **P < 0.01. 6⁄ 6 0 1 5⁄ 6 5⁄ 6 0 0 Asthma 6 ⁄ 7 5⁄ 6 0 1 1⁄ 3 1⁄ 2 0 1 SSRI, selective serotonin re-uptake inhibitors; PLMS, periodic limb movement syndrome ( ‡ 5 movements per hour); Corr ⁄ n, number of correctly classified patients ⁄ the number in the subgroup; Corr ⁄ n excl, the same after excluding patients who failed the CODI self-check; nA, nAv, the number of patients excluded with many more autonomic arousals than resaturations (groups A and Av, see text); nB, nBv, the number of patients excluded with many more resaturations than autonomic arousals (groups B and Bv).
ROC were 0.93 for ODI-2 and 0.94 for CODI on the validation data set. The performance of the ODI-2 was similar to that reported recently by Va´zquez et al. (2000) , who obtained a specificity of 96% and sensitivity of 88% from oximetry, using 4% dips and a sample rate of 1 Hz. Thus, with careful attention to the processing algorithm (Farre´et al. 1998) , the performance of simple oximetry may be better than previously published (Golpe et al. 1999; Ryan et al. 1995) . The CODI provides information relating to autonomic arousal which is not available from simple oximetry. This is discussed further below. It should be stressed that the CODI should not be considered to be an estimate of the AHI, because events that do not meet the criteria for apnoea or hypopnoea can be picked up by the CODI algorithm. Rather, the CODI algorithm gives an estimate of the number of respiratory event-related arousals. This is correlated with the AHI and may therefore be used to predict the presence of the SAHS. It is interesting to note that the CODI was better correlated with the EEG arousal index (r s ¼ 0.84) than the AHI (r s ¼ 0.59, Table 2 ) or ODI-2 (r s ¼ 0.57); similarly, the CODI was better correlated with the Epworth sleepiness score (r s ¼ 0.47) than were the AHI (r s ¼ 0.34) and ODI-2 (r s ¼ 0.38, Table 2) .
A positive screening test result coupled with a strong clinical suspicion of SAHS would allow a patient to proceed directly to a trial of treatment, without the need for PSG (Bennett & Kinnear 1999) . Oximetry (using 2% dips) returned 23 positive results on the development set data, thus eliminating the need for 23 PSGs. On the same data, the CODI algorithm returned 27 positive results. On the validation set, oximetry returned 21 positive results and the CODI 15. The low number of positive results for the CODI on the validation set is due to a high number of failed self-checks, which is discussed further below.
At a threshold of 24 h
)1
, the CODI returned one false positive result on the development set and two on the validation set. Patients who return a false positive result would, according to the diagnostic protocol suggested above, proceed to a trial of treatment, usually nasal CPAP. A patient without the SAHS would be expected to respond poorly to CPAP and would thus be recalled for reassessment using PSG. Interestingly, the patient from the development set who returned a false positive result for the CODI algorithm in fact consented to undertake a therapeutic trial of CPAP, and responded successfully (neither of the two false positive findings on the validation set trialled CPAP).
If the decision threshold for the CODI algorithm is lowered from 24 to 19 h )1 , the performance on the validation set is unchanged. However, the number of false negative results on the development set drops from four to one (the sensitivity becomes 96%), but the number of false positive results rises to 5. These false positive results warrant individual discussion.
One was found to have poorly controlled asthma, which contributed to respiratory distress during sleep. Another was treated for epilepsy with carbamazepine, and a third was unremarkable. The remaining two patients are perhaps more interesting: both complained of excessive daytime sleepiness and both were observed to display PSG characteristics consistent with respiratory effort-related arousals (RERA). Respiratory effort-related arousals are those arousals that occur as a result of rapid increases in respiratory effort, but which do not meet the criteria for hypopnoea or apnoea (American Academy of Sleep Medicine Task Force 1999). The diagnosis of such arousals requires the measurement of oesophageal pressure, which was not part of the PSG recording undertaken in this study. Consequently, no attempt was made to quantify these arousals. However, both patients responded successfully to a therapeutic trial of nasal CPAP. It is plausible that the CODI includes some RERAs that were missed by PSG in these patients; however, a larger study is needed to properly assess the performance of the CODI in this regard.
The patient population used in this study was not well controlled and so it is difficult to make any strong conclusions regarding the effects of comorbidity or pharmacological intervention on the performance of the CODI algorithm. Nonetheless, the CODI algorithm (with the self-check mechanism) did not appear to be unduly affected by the presence of various comorbidities or interventions, including PLMS, asthma and hypertension (Table 3 ). The CODI algorithm requires that an ECG be recorded overnight and thus it may have a future role in cardiological screening. Several patients in this study showed evidence of ventricular extrasystoles and sinus brady dysrhythmia during sleep.
The CODI algorithm provides a mechanism of self-validation, based on the difference between the autonomic arousal index and the resaturation index. Three patients in the development set showed a discrepancy of more than 45 h )1 (group A, see Fig. 2 ), suggesting the presence of autonomic arousals without desaturation. One of these patients was observed to have drunk coffee shortly before bed on the night of the PSG, which may have affected the heart rate response to arousal in this patient. This patient was also one of those observed to display PSG characteristics consistent with RERAs. One of the other patients in this group had a history of head injury and parasomnia (sleep walking). The other patient in group A was unremarkable. Four patients in the validation set also showed a difference of more than 45 h )1 (group Av, Fig. 4) . Two of these patients were found by PSG to have severe PLMS (with 50.5 and 44.0 limb movements per hour). The other two patients in group Av were unremarkable. Four patients in the development set showed a difference between the autonomic arousal and resaturation indices of less than )25 h )1 (group B). This may have been linked to the fact that all four were suffering from conditions causing chronic pain during sleep: osteoarthritis, fibromyalgia, or spondylosis. Fibromyalgia patients are known to show small dips in overnight oximetry in the absence of sleep apnoea (Lario et al. 1996) . Nocturnal pain might also cause sighing during sleep, with corresponding variations in oximetry. The discrepancy between the autonomic arousal index and the resaturation index in these patients may alternatively have been due to pharmacological causes: two of these four patients were taking selective serotonin re-uptake inhibitors (SSRIs), and two were taking non-steroidal anti-inflammatory analgesics (NSAIDs), both of which may cause sleep disruption (Dorsey et al. 1996; Murphy et al. 1994) . One other patient in the development set complained of sleep disruption caused by chronic pain (caused by spondylosis and generalized arthralgia) but did not show a marked difference between the autonomic arousal index and the resaturation index. The arousal and resaturation responses in this patient may have been complicated by pharmacological processes: this patient was using both a hypnotic and an opioid analgesic. Fourteen patients in the validation set showed a difference of less than )25 h )1 (group Bv). Five complained of sleep disruption caused by chronic pain, three were taking SSRIs, three were taking NSAIDs and one patient had a history of poorly controlled type II diabetes (although this patient could not be tested for autonomic neuropathy). However, five of the 14 patients in group Bv were unremarkable and no explanation could be found for the large discrepancy between the arousal and resaturation indices in these patients. It is disappointing that five of the 14 exclusions in group Bv could not be adequately explained; in total, 25 of the 100 CODI results were rejected by the self-check mechanism. The high incidence of rejection in the validation set may indicate that too much effort was spent refining the algorithm on the development data and that perhaps the final algorithm was Ôover-fittedÕ to the development set. The sequential addition of recordings to the development set (see Methods) may also have contributed: a systematic difference between earlier and later recordings would obviously cause differences between the two data sets (although no such systematic difference could be found). Similarly, a change in the make-up of the patient population with time would have affected the two data sets in an unbalanced manner. In recent years the demand for PSG has increased, with the effect that the patients who proceed to PSG are more likely to be those with complex problems. Patients with straightforward clinical presentation of obstructive sleep apnoea may now be diagnosed and proceed to CPAP without undergoing PSG. We would emphasize, however, that regardless of the cause of the higher number of rejections in the validation set, the performance of the CODI algorithm (as a predictor of SAHS) on those patients who passed the selfcheck was not statistically different between the development and validation sets (the areas under the ROC were 0.96 and 0.94).
The difference between the autonomic arousal index and the resaturation index may thus provide an indication of the validity of the CODI values, because the cause of sleep disruption in patients who display a large discrepancy between these indices is less likely to be straightforward SAHS. It could be considered inappropriate for such patients to progress to a trial of treatment without first being reviewed with full PSG. Simple oximetry-based tests provide no such self-check mechanism. As a matter of interest, we assessed the performance of oximetry with the exclusion of those patients who failed the CODI algorithm self-check. On the development set data, excluding these patients improved the performance of oximetry; conversely, the validation set performance of oximetry was generally impaired by such exclusion. The self-check thus cannot be used as a means of identifying patients for whom oximetry might be expected to perform poorly.
The CODI algorithm has quite modest recording and processing requirements and could be implemented in a portable device suitable for domiciliary use. Many oximeters provide an estimate of heart rate; the accuracies of such are probably not sufficient to replace the use of the ECG for estimating autonomic arousal. We found (results not shown) that this signal gave quite poor performance in the context of the CODI algorithm. Furthermore, implementation of the algorithm using an oximeter other than the one we have used here (Minolta Pulsox-7) would require careful attention to the parameters relating to detection of resaturation events (as well as the oximeter sample rate and resolution). The detection of transient changes in oximetry data is known to be affected by oximeter averaging times (Farre´et al. 1998) ; the CODI algorithm employs quite small resaturation levels (1.5%) and its performance will be critically dependent on the acquisition and preprocessing of the oximetry signal. The data used in this study were taken from the first onset of sleep to the last awakening of the night, and although the performance of the algorithm did not appear to be adversely affected by long periods of wakefulness, it may be necessary to provide an estimate of sleep onset and end -perhaps by wristwatch actigraph -if the algorithm is to be used in a domiciliary setting.
CONCLUSIONS
The CODI algorithm is well suited for use as a preliminary screening test for the SAHS and also offers an informal measure of self-validation. The algorithm requires the recording of only the ECG and oximetry signals and could be implemented in a portable device suitable for domiciliary use. The source code is available upon request from the authors.
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